This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
This issue profiles personalized treatment for prostate cancer patients, personal genomics that paves the way for future medicine and health, and gene therapy for ophthalmic diseases.
$250.00 -
This issue profiles a novel drug to treat bile acid synthesis disorders, FDA approval for a drug for treatment of thyroid cancer, and a drug screening technology platform based on modulation of integrin activity.
$950.00 -
This issue profiles an innovative cell-free DNA blood test to detect Down syndrome, a novel experimental vaccine for Ebola, and a novel antibody therapy to reduce HIV loads.
$250.00 -
This issue profiles a nanoparticle-based wound therapy, a cancer drug found to be effective in treating arterio-venous malformations, and a gene responsible for insulin resistance.
$250.00 -
This issue profiles nanotechnology for enhancing drug delivery, building biological optoelectronic probes with CNT transistors, and creating energy storage devices with graphene and nanotube carpets.
$250.00 -
This issue profiles a genetic manipulation tool to induce mutations, oral delivery of influenza vaccines, and oncological conditions treated using cytomegalovirus.
$250.00 -
This issue profiles an adhesive-based closure system to treat varicose veins, a mobile device for diagnosing Parkinson’s Disease, and Holter monitor for continuous ECG monitoring.
$950.00 -
This issue profiles a bacteriophage that aids efforts to destroy Enterococcus Faecalis bacteria, preventing salmonellosis through the usage of lytic bacteriophages, and development of multiple phage therapy products for infectious diseases .
$250.00 -
This issue profiles understanding genes and pathways to optimize drug development, an intralumenal device for transmucosal drug delivery , and next generation protein-based medicines to treat immunological disorders.
$950.00 -
This issue profiles an innovative method to prove accuracy of CRISPR-Cas9 in human cells, herpes simplex virus molecular test that obtains FDA approval, and DNA therapeutic vaccine for human papillomavirus.
$250.00
